detection of rtn236t mutation associated with adefovir dipivoxil resistance in hepatitis b infected patients with ymdd mutations in tehran.

نویسندگان

seyed hamidreza monavari antimicrobial resistance research center, tehran university of medical sciences, tehran, iran.

hossein keyvani department of virology, tehran university of medical sciences, tehran, iran.

hamidreza mollaie department of virology, tehran university of medical sciences, tehran, iran.

rouhollah vahabpour roudsari department of virology, tehran university of medical sciences, tehran, iran.

چکیده

background objectives: the risk of adefovir dipivoxil resistance emergence has increased in lamivudine-resistant hepatitis b infected patients. the mutations known as causing adefovir resistance, rtn236t and rta181v/t, are detected within the d and b functional domain of the hbv polymerase, respectively. in this study, we intended to determine the pre-existing adefovir-resistance mutations in patients infected with lam resistant mutants prior to starting adefovir therapy. material and methods: the study included 30 patients with chronic hepatitis b with lamivudine resistance mutations in the ymdd motif that experienced viral breakthrough. results: after alignment of protein coding sequences, the rtn236t mutation was observed in two (6.6 %) patients, while twenty-eight others had neither rtn236t, nor rta181v/t mutation. all 30 patients were infected with genotype d of hepatitis b virus. conclusions: the early detection of lam-resistance mutations may allow a timely chance of therapy to avoid hepatitis flare- up. this data suggests that monitoring of adv-resistance mutations in adv naïve patients can be considered in selecting the appropriate anti-viral regimen.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Detection of rtN236T mutation associated with adefovir dipivoxil resistance in Hepatitis B infected patients with YMDD mutations in Tehran

BACKGROUND OBJECTIVES The risk of adefovir dipivoxil resistance emergence has increased in lamivudine-resistant hepatitis B infected patients. The mutations known as causing adefovir resistance, rtN236T and rtA181V/T, are detected within the D and B functional domain of the HBV polymerase, respectively. In this study, we intended to determine the pre-existing adefovir-resistance mutations in pa...

متن کامل

Frequency of YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines

 Abstract Background: Investigators were suspicious of tyrosine-methionine-aspartate-aspartate (YMDD) mutations occurred only in patients who were treated by lamivudine. However, YMDD mutations of hepatitis B virus gene (HBV DNA) in patients with chronic hepatitis B (CHB) untreated with antiviral medicines was reported in some studies. The aim of this study was to evaluate YMDD mutations in Ira...

متن کامل

YMDD and FLLAQ Mutations in Chronic Hepatitis B Patients

Abstract Background and Objective: Lamivudine is the first orally available drug approved for treatment of chronic hepatitis B. Mutations at the YMDD and FLLAQ motifs in the domains of HBV polymerase gene contribute resistance to lamivudine. This study was aimed to determine the rate of YMDD and FLLAQ mutants in hepatitis B patients in Golestan Province, Iran. Material and methods: In this cros...

متن کامل

Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).

The nucleotide analog adefovir dipivoxil (ADV) is an effective antiviral treatment for chronic hepatitis B virus (HBV) infection, with resistance to ADV estimated to occur less frequently than resistance to lamivudine treatment. The detection of ADV resistance mutations is necessary during therapy to monitor and anticipate possible treatment failure. The INNO-LiPA HBV DR v2 (LiPA; Innogenetics,...

متن کامل

Adefovir dipivoxil modulates cytokine expression in Th1/Th2 cells in patients with chronic hepatitis B.

The impact of adefovir dipivoxil (ADV) treatment on the immune system in patients with chronic hepatitis B (CHB) is unknown. The present study was designed to determine the expression of six cytokines, IL-2, IFN-γ, TNF-α, IL-4, IL-6 and IL-10, and their correlation with liver functions and clinical responses to ADV treatment. A total of 22 CHB patients were treated with ADV at a daily oral dose...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
iranian journal of microbiology

جلد ۵، شماره ۱، صفحات ۷۶-۸۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023